Clinical Trial Update: Melatonin and Quality of Life in Dialysis Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating melatonin for improving quality of life in dialysis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Sleep Disorders

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Meander Medical Center | Conditions: Sleep Problems, Haemodialysis | Phase 3 | Status: COMPLETED